OpportunityTitle: FDA Drug Residue Cooperative Agreement Program (U18)
AdditionalInformationOnEligibility: Competition is limited to these organizations to improve their current drug residue prevention program(s) and/or develop a stronger foundation to prevent drug residues in animal derived foods through educational outreach, training to industry and individuals to communicate proper drug use and promote effective management practices for drug residue prevention.     Current award recipients under cooperative agreement, RFA-FD-15-025, whom will have their project funded in 2016-2017 are ineligible to apply for this cooperative agreement    Foreign Institutions  Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Description: The intended outcome of this FOA is to advance efforts to improve and develop State drug residue prevention programs. It is necessary to provide assistance to State tissue residue programs that need a stronger foundation to promote the prevention of illegal drug residues in animal derived foods through educational outreach and training, properly communicate and promote effective management practices for drug residue prevention, to increase the knowledge of proper drug use, and support other activities related to drug residue prevention. This FOA is intended to ensure drug residue prevention programs are developed to protect consumer exposure to drug residues in the edible products of food animals. In addition, these awards will help state agencies better direct their programs to reduce the outcomes of illegal drug residues in animal derived foods. This cooperative agreement will further enhance the program by measuring the performance of existing State drug residue prevention program, identifying areas of improvement and/or developing new programs.
GrantorContactEmailDescription: daniel.lukash@fda.hhs.gov
GrantorContactText: Daniel Lukash &lt;br/&gt;Grants Management Specialist &lt;br/&gt;Phone 240-402-7596